CardioDx
Latest round
- Series F
Last raised
- Oct 2012
Total raised
- $210M
Investors
- 14
About CardioDx
Established in 2004 and based in California, US, CardioDx, Inc. operates as a developer of genomic tests to individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias and heart failure.
Who invested in CardioDx
14 investors across 7 rounds
See all investors in CardioDx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Oct 12, 2012
Amount
$29M
Investors
Series F
Aug 16, 2012
Amount
$29M
Investors
Series E
Jun 17, 2011
Amount
$69M
Investors
Series E
Feb 17, 2011
Amount
$2M
Investors
Series D
May 6, 2010
Amount
$35M
Investors
Series C
Oct 1, 2008
Amount
$28M
Investors
Series B
Jul 21, 2006
Amount
$19M
Investors
Questions about CardioDx
Who invested in CardioDx?
CardioDx has 14 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CardioDx raised?
CardioDx has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did CardioDx last raise money?
CardioDx's most recent round on record is a Series F, in Oct 2012.
What does CardioDx do?
Established in 2004 and based in California, US, CardioDx, Inc.
Where is CardioDx headquartered?
CardioDx is headquartered in Redwood City, US.
Which VCs invest in companies like CardioDx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CardioDx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like CardioDx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.